Patients whose tumors had low CD8 to exhausted CD8 scores, or greater abundance of exhausted CD8 T cells, were also more likely to progress to metastatic disease which supports CD8 T-cell anergy and exhaustion as a plausible tolerance mechanism in tumoral immune escape. This evidence concerns the gene CD8A and metastatic neoplasm.